Management of tinea capitis in infants and children in the United States : A national survey of pediatric dermatologists

© 2024 Wiley Periodicals LLC..

This study aimed to evaluate the current management of tinea capitis in the United States, specifically focusing on patients aged 0-2 months, 2 months to 2 years, and 2 years to 18 years. An online survey, distributed through the Pediatric Dermatology Research Alliance and the Society of Pediatric Dermatology, revealed the following preferences: fluconazole for those under 2 months, griseofulvin for those aged 2 months to 2 years, and terbinafine for those aged 2 years and older. There exists inter-provider variation in tinea capitis treatment regimens within the pediatric dermatology community.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:41

Enthalten in:

Pediatric dermatology - 41(2024), 2 vom: 18. März, Seite 263-265

Sprache:

Englisch

Beteiligte Personen:

Guo, Lily [VerfasserIn]
Tran, Jacqueline [VerfasserIn]
Sun, Dingyuan Iris [VerfasserIn]
Newton, Jazmin Starr [VerfasserIn]
D'Amiano, Nina M [VerfasserIn]
Lai, Jonathan [VerfasserIn]
Cohen, Bernard [VerfasserIn]

Links:

Volltext

Themen:

304NUG5GF4
32HRV3E3D5
Antifungal Agents
Bacterial infections and mycoses
Dermatomycoses
Fungal infection
Griseofulvin
Hair disorders
Infectious skin diseases
Itraconazole
Journal Article
Naphthalenes

Anmerkungen:

Date Completed 19.03.2024

Date Revised 19.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/pde.15544

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368321436